US Patent 11911471 Anaerobic blood storage and pathogen inactivation method
Patent 11911471 was granted and assigned to Hemanext on February, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+56 properties)
Article (+516 characters)
US Patent 11911471 Anaerobic blood storage and pathogen inactivation method
Article
Patent abstract
A method for reducing hemolysis and microparticle formation during storage of pathogen reduced blood. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced hemolysis. Oxygen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles. Oxygen and pathogen reduced blood compositions comprising CPAD and riboflavin having reduced hemolysis. Oxygen and pathogen reduced blood compositions comprising SAGM and riboflavin having reduced microparticles.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Jeffrey Sutton0
Samuel O. Sowemimo-Coker0
Tatsuro Yoshida0
Date of Patent
February 27, 2024
0Patent Application Number
174828460
Date Filed
September 23, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11911471 Anaerobic blood storage and pathogen inactivation method
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.